skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Bone marrow glucose metabolic response to GMCSF by quantitative FDG PET imaging

Journal Article · · Journal of Nuclear Medicine
OSTI ID:197886
; ;  [1]
  1. UCLA School of Medicine, Los Angeles, CA (United States); and others

To evaluate noninvasively the recombinant granulocyte-macrophage colony-stimulating factor (GMCSF) effects on bone marrow glucose metabolism, we studied 18 patients with metastatic melanoma with quantitative FDG PET imaging. All patients received 14 days of therapy in 3 groups; group 1: 4 patients treated with GMCSF (5 ug/kg/d SQ), group 2: 8 patients treated with GMCSF (5 ug/kg/d SQ) and monoclonal antibody MAbR24, and group 3: 6 patients treated with MCSF (80 ug/kg/d IVCI) and MAbR24.

OSTI ID:
197886
Report Number(s):
CONF-940605-; ISSN 0161-5505; TRN: 95:007029-0009
Journal Information:
Journal of Nuclear Medicine, Vol. 35, Issue Suppl.5; Conference: 41. annual meeting of the Society of Nuclear Medicine, Orlando, FL (United States), 5-8 Jun 1994; Other Information: PBD: May 1994
Country of Publication:
United States
Language:
English